Biomedicines (Dec 2020)

The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression

  • Federica Caponnetto,
  • Emiliano Dalla,
  • Damiano Mangoni,
  • Silvano Piazza,
  • Slobodanka Radovic,
  • Tamara Ius,
  • Miran Skrap,
  • Carla Di Loreto,
  • Antonio Paolo Beltrami,
  • Ivana Manini,
  • Daniela Cesselli

DOI
https://doi.org/10.3390/biomedicines8120564
Journal volume & issue
Vol. 8, no. 12
p. 564

Abstract

Read online

Low-grade gliomas (LGG) are infiltrative primary brain tumors that in 70% of the cases undergo anaplastic transformation, deeply affecting prognosis. However, the timing of progression is heterogeneous. Recently, the tumor microenvironment (TME) has gained much attention either as prognostic factor or therapeutic target. Through the release of extracellular vesicles, the TME contributes to tumor progression by transferring bioactive molecules such as microRNA. The aim of the study was to take advantage of glioma-associated stem cells (GASC), an in vitro model of the glioma microenvironment endowed with a prognostic significance, and their released exosomes, to investigate the possible role of exosome miRNAs in favoring the anaplastic transformation of LGG. Therefore, by deep sequencing, we analyzed and compared the miRNA profile of GASC and exosomes obtained from LGG patients characterized by different prognosis. Results showed that exosomes presented a different signature, when compared to their cellular counterpart and that, although sharing several miRNAs, exosomes of patients with a bad prognosis, selectively expressed some miRNAs possibly responsible for the more aggressive phenotype. These findings get insights into the value of TME and exosomes as potential biomarkers for precision medicine approaches aimed at improving LGG prognostic stratification and therapeutic strategies.

Keywords